Feasibility of Immunotherapy Plus Chemotherapy Administration to Patients With Bronchial Cancer in a Hospital-at- Home Setting (CombHADom)
Feasibility of Immunotherapy Plus Chemotherapy Administration to Patients With Bronchial Cancer in a Hospital-at- Home Setting - CombHADom
Sponsor: Centre Hospitalier de PAU
A observational or N/A phase clinical study on Bronchial Cancer, this trial is completed. The trial is conducted by Centre Hospitalier de PAU and has accumulated 7 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Mar 2024 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Apr 2023 — Mar 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Nov 2021 — Apr 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
▶ Show 2 earlier versions
-
Sep 2021 — Nov 2021 [monthly]
Not Yet Recruiting
-
Apr 2021 — Sep 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier de PAU
For direct contact, visit the study record on ClinicalTrials.gov .